JP Morgan Chase’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

JP Morgan Chase’s Portfolio XAGE Stock Details XAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Hold	0	–	-$2	–	7838
2025 Q1	–	Hold	0	–	–	–	7259
2024 Q4	–	Sell	-1	Closed	-$10	–	7343
2024 Q3	$13	Sell	1 -1	-50%	-$27	﹤0.01%	7276
2024 Q2	$60	Buy	+2	New	+$132	﹤0.01%	6993
2024 Q1	–	Hold	0	–	–	–	7182
2023 Q4	–	Hold	0	–	–	–	7439
2023 Q3	–	Sell	-27,389	Closed	-$4.13M	–	7378
2023 Q2	$8.48M	Sell	27,389 -9,844	-26%	-$3.02M	﹤0.01%	2427
2023 Q1	$11.3M	Buy	+37,233	New	+$11.2M	﹤0.01%	2170

Other funds holding XAGE

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CMU

Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $915M AUM 19.16% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

JP Morgan Chase's XAGE Position: Q2 2025 in Review

JP Morgan Chase held its Longevity Health Holdings, Inc. Common Stock (XAGE) position steady in Q2 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7838.

JP Morgan Chase first reported a position in XAGE in Q1 2023 and has held it in 4 quarters since. The position peaked at $11.3M in Q1 2023. 11 funds tracked by Wall St. Rank hold XAGE as of Q2 2025.

JP Morgan Chase held 0 shares of Longevity Health Holdings, Inc. Common Stock worth $0 as of Q2 2025.
JP Morgan Chase left its Longevity Health Holdings, Inc. Common Stock share count unchanged in Q2 2025.
Longevity Health Holdings, Inc. Common Stock made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2025, its #7838 holding.
JP Morgan Chase first reported a position in Longevity Health Holdings, Inc. Common Stock in Q1 2023 and has held it in 4 quarters since.
JP Morgan Chase's Longevity Health Holdings, Inc. Common Stock position peaked at $11.3M in Q1 2023.
11 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.